Businessweek

packs, and other disposable products for cataract and vitreoretinal surgery. Ophthalmic Pharmaceuticals The company’s Alcon division's Ophthalmic Pharmaceuticals business combines Alcon's range of pharmaceuticals with selected ophthalmic products (excluding Lucentis). The products treat chronic and acute conditions of the eye, including glaucoma, elevated intraocular pressure (associated with glaucoma), eye infection and inflammation, eye allergies, and dry eye. Its Alcon division's Ophthalmic Pharmaceuticals business also oversees the line of professionally driven OTC brands that include artificial tears and ocular vitamins. Product highlights within its Alcon division's Ophthalmic Pharmaceuticals portfolio include Travatan Z ophthalmic solution and DuoTrav ophthalmic solution for the treatment of elevated intraocular pressure associated with glaucoma; Vigamox ophthalmic solution for bacterial conjunctivitis; Pataday ophthalmic solution for ocular itching associated with allergic conjunctivitis; Nevanac ophthalmic suspension for eye inflammation following cataract surgery; and the Systane family of OTC products for dry eye relief. Vision Care The company’s Alcon division's Vision Care business combines the portfolio of contact lenses and lens care products with Alcon's contact lens care solution portfolio. This includes the Opti-Free line of multi-purpose disinfecting solutions, as well as the Clear Care and AOSept Plus hydrogen peroxide lens care solutions. Alcon also offers a portfolio of silicone hydrogel, daily disposables, and color contact lenses, including its Air Optix, Dailies, and Freshlook brands, as well as its innovation of Dailies Total1. Through the integration of CIBA Vision products, Alcon is the major manufacturer across contact lenses and lens care products. New Products Alcon launched various products in 2012, and also received various primary approvals, such as: Dailies Total1 lenses: Water gradient daily disposable contact lenses received the U.S. and Japan approval in 2012. Also in 2012, Dailies Total1 contact lenses launched in Germany, Austria, Italy, and France. Opti-Free PureMoist: Multi purpose disinfecting solution launched throughout 2012 in various Asian countries (including Japan and Singapore), Europe (including Russia and Italy), and South America. Air Optix Night and Day Aqua: Silicone hydrogel contact lenses launched throughout 2012 in South Africa and Australia, as well as in select countries in Europe, Latin and South America, and Asia. Dailies Illuminate: Color contact lenses introduced the new color, Rich Brown, in Japan, Hong Kong, Malaysia, and Korea. AcrySof IQ ReSTOR +2.5D Multifocal IOL and AcrySof IQ ReSTOR +2.5D Multifocal Toric IOL: Technology intra-ocular lenses launched in countries that recognize the CE Mark in September 2012 as a line extension of the marketed AcrySof IQ ReSTOR +3.0D Multifocal IOL and AcrySof IQ ReSTOR+3.0D Multifocal Toric IOL. Technology IOL lenses correct cataracts, as well as refractive errors, such as presbyopia and astigmatism, offering improved near and intermediate vision. LenSx: Femtosecond cataract refractive laser received additional indication by the FDA, and could be used for corneal flap creation during refractive surgical procedures. LenSx SoftFit Patient Interface: Alcon's innovation introduced within the LenSx laser platform launched in the U.S. for use during cataract surgery, enabling easier docking, free floating capsulotomies, lower intra-ocular pressure, and improved surgical performance. Centurion: Alcon's next generation phacoemulsification system received FDA approval to perform cataract surgeries. LuxOR Ophthalmic Microscope: Re-launched in the U.S. in July 2012. This addition improves Alcon's surgical portfolio by expanding into the optical microscope segment of the market, and offering a solution for improved intra-operative visualization. Durezol: FDA approval received for the indication of uveitis. The product is indicated for use as an anti-inflammatory for the eye post-surgery. The new indication for uveitis would treat inflammation in the uvea near the middle of the eye.